Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients

ConditionBronchiolitis Obliterable Syndrome

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorNational Taiwan University Hospital

About this trial

Prospective observational study on the clinical characteristics of pulmonary graft-versus-host disease in patients after hematopoietic stem cell transplantation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age>18

Will Receive first time Allo-HSCT patients

Disqualifiers

Respiratory failure

Hemodynamic unstable

Pneumothorax or bronchial fistula

Acute coronary syndrome in recent 1 month

Trial population

At National Taiwan University Hospital and National Taiwan University Hospital Cancer Center

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

600 Participants

are grouped into 1 trial group

Group A: A hematopoietic stem cell transplantation cohort

Trial outcomes

Primary outcomes

Prevalence of bronchiolitis obliterans syndrome

Time frame

From enrollment to the end of treatment at 2 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

National Taiwan University Hospital

Lead sponsor

Source ClinicalTrials.gov

Apply now